All lobbying filings
STANTON PARK GROUP
Lobbying for BRAEBURN PHARMACEUTICALS, INC. · pharmaceutical company
Filing
2nd Quarter - Report
Lobbying activity
2
Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; Patient access to practitioner-administered therapies; MAT availability in federal prisons
Pilot programs related to Medicaid pricing